Table 2.
Cerebrospinal Fluid Neuroactive Steroid Indices (pg/ml) | TC Mean ± SD (n) |
PTSD Mean ± SD (n) |
ta | dfa | Pa | Cohen’s d [95% CI]a |
---|---|---|---|---|---|---|
Progesterone | 13.0 ± 12.2 | 17.1 ± 11.6 | 0.87 | 23.7 | .39 | 0.34 [−0.47; 1.16] |
(PROG) | (14) | (12) | 0.61 | 20.0 | .55 | 0.26 [−0.62; 1.13] |
5α-Dihydroprogesterone: | 573.7 ± 669.7 | 309.4 ± 293.7 | −1.37 | 20.1 | .19 | −0.53 [−1.34; 0.28] |
(5α-DHP) | (15) | (12) | −1.68 | 21.0 | .11 | −0.69 [−1.58; 0.19] |
Allopregnanolone: | 18.2 ± 10.6 | 15.1 ± 9.7 | −0.78 | 24.5 | .44 | −0.30 [−1.10; 0.50] |
(Allo) | (15) | (12) | −0.98 | 21.0 | .34 | −0.41 [−1.27; 0.46] |
Pregnanolone: | 5.1 ± 4.1 | 17.0 ± 23.6 | 1.72 | 11.5 | .11 | 0.67 [−0.15; 1.49] |
(Pregnan) | (15) | (12) | 1.71 | 21.0 | .10 | 0.71 [−0.18; 1.59] |
Allo + Pregnan | 23.3 ± 10.6 | 32.1 ± 23.7 | 1.20 | 14.5 | .25 | 0.46 [−0.34; 1.27] |
(15) | (12) | 1.00 | 21.0 | .33 | 0.41 [−0.46; 1.28] | |
Dehydroepiandrosterone: | 839.4 ± 889.0 | 618.9 ± 479.3 | −0.87 | 25.6 | .39 | −0.32 [−1.08; 0.44] |
(DHEA) | (17) | (13) | −1.28 | 24.0 | .21 | −0.50 [−1.32; 0.32] |
DHEA-Sulfate: | 2121 ± 1572 | 2059 ± 2087 | −0.09 | 19.7 | .93 | −0.03 [−0.82; 0.75] |
(DHEAS) | (16) | (12) | −0.16 | 22.0 | .87 | −0.07 [−0.91; 0.78] |
Plasma | ||||||
Adrenocorticotropic Hormone (ACTH) | 26.6 ± 17.8 | 21.5 ± 10.7 | −0.92 | 24.7 | .36 | −0.36 [−1.17; 0.45] |
(16) | (11) | |||||
Ratios Indicating Possible Enzyme Blocks in the Allo and Pregnan Synthesis Pathways | ||||||
5α-DHP/PROG | 64.1 ± 60.4 | 25.8 ± 24.2 | −2.09 | 16.3 | .05t | −0.86 [−1.75; 0.03] |
(13) | (11) | −2.14 | 18.0 | <.05* | −0.94 [−1.91; 0.03] | |
Allo/5α-DHP | 0.11 ± 0.21 | 0.12 ± 0.17 | 0.18 | 23.9 | 0.86 | 0.07 [−0.74; 0.18] |
(14) | (12) | 0.48 | 20.0 | 0.64 | 0.20 [−0.68; 1.08] | |
Ratios Integrating Possible Synthesis Blocks Across Neurosteroidogenesis | ||||||
(Allo + Pregnan)/5α-DHP | 0.13 ± 0.25 | 0.36 ± 0.58 | 1.30 | 14.4 | .21 | 0.51 [−0.31; 1.34] |
(14) | (12) | 1.55 | 20.0 | .14 | 0.65 [−0.25; 1.55] | |
PROG/ACTH | 0.75 ± 0.83 | 0.93 ± 0.49 | 0.65 | 19.9 | .52 | 0.27 [−0.61; 1.15] |
(13) | (10) | |||||
(Allo + Pregnan)/ACTH | 1.27 ± 1.11 | 1.76 ± 1.84 | 0.75 | 13.6 | .47 | 0.31 [−0.55; 1.17] |
(14) | (10) | |||||
Ratios Reflecting | ||||||
Inhibitory to Excitatory Neurotransmission Balance | ||||||
(Allo + Pregnan)/DHEA | 0.047 ± 0.03 | 0.116 ± 0.15 | 1.56 | 11.9 | .14 | 0.61 [−0.21; 1.42] |
(15) | (12) | 1.85 | 21.0 | .08 | 0.76 [−0.12; 1.65] | |
(Allop + Pregnan)/DHEAS | 0.016 ± 0.01 | 0.035 ± 0.05 | 1.28 | 12.5 | .22 | 0.50 [−0.31; 1.31] |
(15) | (12) | 1.38 | 21.0 | .18 | 0.57 [−0.31; 1.44] |
Note:
The first line of results for each biomarker is for the unadjusted t-test (using Welch’s correction for unequal variances); the second line reports the adjusted statistics controlling for plasma ACTH levels. t = 0.05 ≤ p < 0.10;
= p < 0.05.